Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Non-Current Deferred Tax Liability (2016 - 2025)

Haemonetics has reported Non-Current Deferred Tax Liability over the past 16 years, most recently at $56.0 million for Q4 2025.

  • Quarterly results put Non-Current Deferred Tax Liability at $56.0 million for Q4 2025, down 8.9% from a year ago — trailing twelve months through Dec 2025 was $56.0 million (down 8.9% YoY), and the annual figure for FY2025 was $62.6 million, changed 0.11%.
  • Non-Current Deferred Tax Liability for Q4 2025 was $56.0 million at Haemonetics, down from $58.2 million in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for HAE hit a ceiling of $120.9 million in Q2 2021 and a floor of $24.3 million in Q3 2021.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $58.8 million (2025), compared with a mean of $56.8 million.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: surged 166.57% in 2022 and later crashed 44.31% in 2024.
  • Haemonetics' Non-Current Deferred Tax Liability stood at $24.6 million in 2021, then soared by 63.39% to $40.2 million in 2022, then surged by 55.03% to $62.2 million in 2023, then decreased by 1.28% to $61.5 million in 2024, then decreased by 8.9% to $56.0 million in 2025.
  • The last three reported values for Non-Current Deferred Tax Liability were $56.0 million (Q4 2025), $58.2 million (Q3 2025), and $59.5 million (Q2 2025) per Business Quant data.